FDA
approval
· 2018-12-20
FDA Approved: ELEPSIA XR 1000 MG — Original Application (TRIPOINT THERAPEUTICS, LLC)
Summary
The FDA approved Elepsia XR 1000 mg, an extended-release formulation of levetiracetam, under an original NDA from TriPoint Therapeutics.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ELEPSIA XR 1000 MG (LEVETIRACETAM)